NO974995D0 - Estere av karbapenemer - Google Patents

Estere av karbapenemer

Info

Publication number
NO974995D0
NO974995D0 NO974995A NO974995A NO974995D0 NO 974995 D0 NO974995 D0 NO 974995D0 NO 974995 A NO974995 A NO 974995A NO 974995 A NO974995 A NO 974995A NO 974995 D0 NO974995 D0 NO 974995D0
Authority
NO
Norway
Prior art keywords
carbapenems
esters
Prior art date
Application number
NO974995A
Other languages
English (en)
Other versions
NO974995L (no
Inventor
George Burton
Stephen Christopher Marti Fell
Stephen Frederick Moss
Alfred John Eglington
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9508960.3A external-priority patent/GB9508960D0/en
Priority claimed from GBGB9508959.5A external-priority patent/GB9508959D0/en
Priority claimed from GBGB9508964.5A external-priority patent/GB9508964D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO974995D0 publication Critical patent/NO974995D0/no
Publication of NO974995L publication Critical patent/NO974995L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • C07D477/06Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D477/08Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
NO974995A 1995-05-03 1997-10-30 Estere av karbapenemer NO974995L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9508960.3A GB9508960D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508959.5A GB9508959D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508964.5A GB9508964D0 (en) 1995-05-03 1995-05-03 Novel compounds
PCT/EP1996/001882 WO1996034869A1 (en) 1995-05-03 1996-05-02 Esters of carbapenems

Publications (2)

Publication Number Publication Date
NO974995D0 true NO974995D0 (no) 1997-10-30
NO974995L NO974995L (no) 1997-10-30

Family

ID=27267697

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974995A NO974995L (no) 1995-05-03 1997-10-30 Estere av karbapenemer

Country Status (14)

Country Link
EP (1) EP0823911A1 (no)
JP (1) JPH11504912A (no)
KR (1) KR19990008354A (no)
CN (1) CN1184480A (no)
AU (1) AU5814196A (no)
BR (1) BR9608318A (no)
CA (1) CA2217885A1 (no)
CZ (1) CZ347697A3 (no)
HU (1) HUP9801061A3 (no)
MX (1) MX9708422A (no)
NO (1) NO974995L (no)
PL (1) PL323148A1 (no)
TR (1) TR199701289T2 (no)
WO (1) WO1996034869A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100771019B1 (ko) * 2002-03-20 2007-10-29 주식회사 만도 브레이크 액압제어장치
GB0400329D0 (en) * 2004-01-08 2004-02-11 Glaxo Group Ltd Novel processes
GB0400405D0 (en) * 2004-01-09 2004-02-11 Glaxo Group Ltd Novel processes
JP2007039383A (ja) * 2005-08-03 2007-02-15 Dainippon Sumitomo Pharma Co Ltd アリールカルバペネム化合物の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
DK637888A (da) * 1987-11-24 1989-05-25 Hoffmann La Roche Carboxylsyreestere
GB8809534D0 (en) * 1988-04-22 1988-05-25 Beecham Group Plc Novel compounds
SK53696A3 (en) * 1993-10-29 1996-10-02 Smithkline Beecham Plc Carbapenem derivatives, their preparation, pharmaceutical compositions containing them and their use

Also Published As

Publication number Publication date
CZ347697A3 (cs) 1998-06-17
CN1184480A (zh) 1998-06-10
MX9708422A (es) 1998-02-28
TR199701289T2 (xx) 1998-08-21
BR9608318A (pt) 1999-01-26
AU5814196A (en) 1996-11-21
JPH11504912A (ja) 1999-05-11
KR19990008354A (ko) 1999-01-25
HUP9801061A2 (hu) 1998-08-28
HUP9801061A3 (en) 1999-01-28
PL323148A1 (en) 1998-03-16
EP0823911A1 (en) 1998-02-18
CA2217885A1 (en) 1996-11-07
WO1996034869A1 (en) 1996-11-07
NO974995L (no) 1997-10-30

Similar Documents

Publication Publication Date Title
NO976158D0 (no) Azetidinon-derivater for behandling av atherosklerose
PT874854E (pt) Antibioticos de cefalosporina
BR9610022A (pt) Esteres
FI973500A (fi) 3-pyrrolidylideeni-2-oni-kefalosporiinien johdannaiset
NO974995D0 (no) Estere av karbapenemer
NO974994D0 (no) Estere av karbapenemer
NO980862D0 (no) Zwitterinoformer av trovafloxacin
FI942576A0 (fi) Behandling av plasma
FI951329A (fi) Prostaglandiinin F estereitä
NO964685L (no) Isomering av equilin
FI951071A0 (fi) Maetanordning foer maetning av stroemmen i medelspaenningsledningar
KR970048178U (ko) 텔레비전의 의사스테레오신호 제어장치
FI950355A0 (fi) Foerfarande foer taeckande av soetheten i mjoelkprodukt
PT761766E (pt) Compostos assimetricos de trifenilenodioxazina
SE9404493D0 (sv) Distribution av mjukvara
NO980913L (no) Alternativ krystallform av tazofelon
FI953754A0 (fi) Foerfarande foer sammanfogning av byggnadsdelar vid varandra
FI952413A0 (fi) Foerfarande foer oeppnande av buken vid fiskrensningsmaskin
FI962394A0 (fi) Hjaelpmedel foer anvaendning vid kontroll av sjaelvlaosande brunnslocks laosningsingrepp
FI956134A0 (fi) Foerfarande foer reglering av frekvensaotergivning vid ljudaotergivning
FI951032A0 (fi) Stommaterial foer gjutmassa vid framstaellning av eldstadselement
FI952897A0 (fi) Foerfarande foer framstaellning av tryckmoenster vid serigrafi
FIU950453U0 (fi) Aeggkopp av kartong
KR970011853U (ko) 새로운 형태의 메리야스
FI1977U1 (fi) Barskaop i form av en brasugn